RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Dorin-Bogdan Borza to Female

This is a "connection" page, showing publications Dorin-Bogdan Borza has written about Female.
Connection Strength

0.270
  1. Caza TN, Arivett BA, Hassen SI, Al-Rabadi LF, Takayama S, Ibrahim A, Larsen CP, Borza DB. Detection and characterization of NELL1 autoantibodies in NELL1 positive membranous nephropathy. Kidney Int. 2025 Sep; 108(3):427-432.
    View in: PubMed
    Score: 0.057
  2. Shen CR, Jia XY, Luo W, Olaru F, Cui Z, Zhao MH, Borza DB. Laminin-521 is a Novel Target of Autoantibodies Associated with Lung Hemorrhage in Anti-GBM Disease. J Am Soc Nephrol. 2021 08; 32(8):1887-1897.
    View in: PubMed
    Score: 0.043
  3. Abrahamson DR, Steenhard BM, Stroganova L, Zelenchuk A, St John PL, Petroff MG, Patarroyo M, Borza DB. Maternal alloimmune IgG causes anti-glomerular basement membrane disease in perinatal transgenic mice that express human laminin a5. Kidney Int. 2019 12; 96(6):1320-1331.
    View in: PubMed
    Score: 0.038
  4. Borza DB. IgG4-restricted anti-glomerular basement membrane autoantibodies targeting quaternary epitopes of native a345(IV) collagen. Am J Kidney Dis. 2014 Jul; 64(1):156-7.
    View in: PubMed
    Score: 0.027
  5. Olaru F, Wang XP, Luo W, Ge L, Miner JH, Kleinau S, Geiger XJ, Wasiluk A, Heidet L, Kitching AR, Borza DB. Proteolysis breaks tolerance toward intact a345(IV) collagen, eliciting novel anti-glomerular basement membrane autoantibodies specific for a345NC1 hexamers. J Immunol. 2013 Feb 15; 190(4):1424-32.
    View in: PubMed
    Score: 0.024
  6. Ho J, Gibson IW, Zacharias J, Fervenza F, Colon S, Borza DB. Antigenic heterogeneity of IgA anti-GBM disease: new renal targets of IgA autoantibodies. Am J Kidney Dis. 2008 Oct; 52(4):761-5.
    View in: PubMed
    Score: 0.018
  7. Kuang H, Wang BN, Jia XY, Cui Z, Yu XJ, Jiang N, Borza DB, Zhao MH. Perlecan is a novel target of autoantibodies in anti-glomerular basement membrane disease. Nephrol Dial Transplant. 2025 Dec 23; 41(1):55-66.
    View in: PubMed
    Score: 0.015
  8. Wang XP, Fogo AB, Colon S, Giannico G, Abul-Ezz SR, Miner JH, Borza DB. Distinct epitopes for anti-glomerular basement membrane alport alloantibodies and goodpasture autoantibodies within the noncollagenous domain of alpha3(IV) collagen: a janus-faced antigen. J Am Soc Nephrol. 2005 Dec; 16(12):3563-71.
    View in: PubMed
    Score: 0.015
  9. Kuang H, Shen CR, Jia XY, Tan M, Yang XF, Cui Z, Borza DB, Zhao MH. Autoantibodies against laminin-521 are pathogenic in anti-glomerular basement membrane disease. Kidney Int. 2023 12; 104(6):1124-1134.
    View in: PubMed
    Score: 0.013
  10. Sueki H, Sato Y, Ohtoshi S, Nakada T, Yoshimura A, Tateishi C, Borza DB, Fader W, Ghohestani RF, Hirako Y, Koga H, Ishii N, Tsuchisaka A, Qian H, Li X, Hashimoto T. A case of subepidermal blistering disease with autoantibodies to multiple laminin subunits who developed later autoantibodies to alpha-5 chain of type IV collagen associated with membranous glomerulonephropathy. Acta Derm Venereol. 2015 Sep; 95(7):826-9.
    View in: PubMed
    Score: 0.007
  11. Becknell B, Zender GA, Houston R, Baker PB, McBride KL, Luo W, Hains DS, Borza DB, Schwaderer AL. Novel X-linked glomerulopathy is associated with a COL4A5 missense mutation in a non-collagenous interruption. Kidney Int. 2011 Jan; 79(1):120-7.
    View in: PubMed
    Score: 0.005
  12. Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, Wieslander J, Kashtan C, Borza DB, Neilson EG, Wilson CB, Hudson BG. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010 Jul 22; 363(4):343-54.
    View in: PubMed
    Score: 0.005
  13. Xu H, Hu F, Sado Y, Ninomiya Y, Borza DB, Ungvari Z, Lagamma EF, Csiszar A, Nedergaard M, Ballabh P. Maturational changes in laminin, fibronectin, collagen IV, and perlecan in germinal matrix, cortex, and white matter and effect of betamethasone. J Neurosci Res. 2008 May 15; 86(7):1482-500.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support